Fundraising Fox
Passkey
9 employees on LinkedIn · 3 known investors
Find your way into Passkey
Sign up to see every warm intro you have to Passkey
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Passkey team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Passkey operates Locksmith, a computational platform that uses human genetics, biology, and pharmacology to identify synergistic drug combinations from approved and late-stage drugs, allowing existing assets to be repurposed for new indications. The company partners with pharmaceutical firms to map clinic-ready combinations that bypass preclinical development and move directly to human trials, initially targeting complex diseases such as cancer.
Investors · 3
How we know: Breakout Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Wireframe Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Passkey do?
- Passkey operates Locksmith, a computational platform that uses human genetics, biology, and pharmacology to identify synergistic drug combinations from approved and late-stage drugs, allowing existing assets to be repurposed for new indications. The company partners with pharmaceutical firms to map clinic-ready combinations that bypass preclinical development and move directly to human trials, initially targeting complex diseases such as cancer.
- Who are Passkey's investors?
- Passkey's investors include Bison Ventures, Breakout Ventures, Wireframe Ventures.